期刊文献+
共找到8篇文章
< 1 >
每页显示 20 50 100
基因编辑技术及其在疾病治疗中的研究进展 被引量:15
1
作者 牛煦然 尹树明 +2 位作者 陈曦 邵婷婷 李大力 《遗传》 CAS CSCD 北大核心 2019年第7期582-598,共17页
基因编辑是一种基于人工核酸酶的遗传操作技术,能精确地对DNA或RNA进行高效改造。基因编辑除了在基础研究、生物育种和药物筛选等方面展现了巨大前景之外,在疾病治疗(特别是基因遗传病)领域的前景与进展尤为引人注目。本文在介绍基因编... 基因编辑是一种基于人工核酸酶的遗传操作技术,能精确地对DNA或RNA进行高效改造。基因编辑除了在基础研究、生物育种和药物筛选等方面展现了巨大前景之外,在疾病治疗(特别是基因遗传病)领域的前景与进展尤为引人注目。本文在介绍基因编辑技术的发展及其在疾病治疗中不同策略的基础上,重点围绕遗传疾病的基因治疗研究,综述了基因编辑技术(包括单碱基编辑和表观调控等技术)在血液系统、肝脏、肌肉和神经系统等疾病治疗的研究进展,并对基因编辑治疗疾病的未来发展进行了展望。 展开更多
关键词 基因编辑 基因治疗 遗传病
下载PDF
Corrigendum to“Long-term correction of hemophilia B through CRISPR/Cas9 induced homology-independent targeted integration”[Journal of Genetics and Genomics(2022)49,1114-1126]
2
作者 Xi Chen Xuran Niu +14 位作者 Yang Liu Rui Zheng Lei Yang Jian Lu shuming yin Yu Wei Jiahao Pan Ahmed Sayed Xueyun Ma Meizhen Liu Fengxiang Jing Mingyao Liu Jiazhi Hu Liren Wang Dali Li 《Journal of Genetics and Genomics》 SCIE CAS CSCD 2024年第5期578-578,共1页
The authors regret that the grant number“21CJ1402200”in the Acknowledgments session should be replaced as“21JC1402200”.The corrected contents areprovided as follows.
关键词 CRISPR/Cas9 CORRECTION ledgment
原文传递
A de novo missense mutation in MPP2 confers an increased risk of Vogt–Koyanagi–Harada disease as shown by trio-based whole-exome sequencing 被引量:1
3
作者 Xianyang Liu Jiayu Meng +13 位作者 Xingyun Liao Yusen Liu Qian Zhou Zongren Xu shuming yin Qingfeng Cao Guannan Su Siyuan He Wanqian Li Xiaotang Wang Guoqing Wang Dali Li Peizeng Yang Shengping Hou 《Cellular & Molecular Immunology》 SCIE CAS CSCD 2023年第11期1379-1392,共14页
Vogt–Koyanagi–Harada(VKH)disease is a leading cause of blindness in young and middle-aged people.However,the etiology of VKH disease remains unclear.Here,we performed the first trio-based whole-exome sequencing stud... Vogt–Koyanagi–Harada(VKH)disease is a leading cause of blindness in young and middle-aged people.However,the etiology of VKH disease remains unclear.Here,we performed the first trio-based whole-exome sequencing study,which enrolled 25 VKH patients and 50 controls,followed by a study of 2081 VKH patients from a Han Chinese population to uncover detrimental mutations.A total of 15 de novo mutations in VKH patients were identified,with one of the most important being the membrane palmitoylated protein 2(MPP2)p.K315N(MPP2-N315)mutation.The MPP2-N315 mutation was highly deleterious according to bioinformatic predictions.Additionally,this mutation appears rare,being absent from the 1000 Genome Project and Genome Aggregation Database,and it is highly conserved in 10 species,including humans and mice.Subsequent studies showed that pathological phenotypes and retinal vascular leakage were aggravated in MPP2-N315 mutation knock-in or MPP2-N315 adeno-associated virus-treated mice with experimental autoimmune uveitis(EAU).In vitro,we used clustered regularly interspaced short palindromic repeats(CRISPR‒Cas9)gene editing technology to delete intrinsic MPP2 before overexpressing wild-type MPP2 or MPP2-N315.Levels of cytokines,such as IL-1β,IL-17E,and vascular endothelial growth factor A,were increased,and barrier function was destroyed in the MPP2-N315 mutant ARPE19 cells.Mechanistically,the MPP2-N315 mutation had a stronger ability to directly bind to ANXA2 than MPP2-K315,as shown by LC‒MS/MS and Co-IP,and resulted in activation of the ERK3/IL-17E pathway.Overall,our results demonstrated that the MPP2-K315N mutation may increase susceptibility to VKH disease. 展开更多
关键词 Vogt-Koyanagi-Harada disease Whole exome sequencing De novo mutation Membrane palmitoylated protein 2 Annexin A2 ERK3/IL-17E pathway
原文传递
Enhanced genome editing to ameliorate a genetic metabolic liver disease through co-delivery of adeno-associated virus receptor 被引量:2
4
作者 shuming yin Lie Ma +14 位作者 Tingting Shao Mei Zhang Yuting Guan Liren Wang Yaqiang Hu Xi Chen Honghui Han Nan Shen Wenjuan Qiu Hongquan Geng Yongguo Yu Shichang Li Weishi Yu Mingyao Liu Dali Li 《Science China(Life Sciences)》 SCIE CAS CSCD 2022年第4期718-730,共13页
Genome editing through adeno-associated viral(AAV) vectors is a promising gene therapy strategy for various diseases,especially genetic disorders. However, homologous recombination(HR) efficiency is extremely low in a... Genome editing through adeno-associated viral(AAV) vectors is a promising gene therapy strategy for various diseases,especially genetic disorders. However, homologous recombination(HR) efficiency is extremely low in adult animal models. We assumed that increasing AAV transduction efficiency could increase genome editing activity, especially HR efficiency, for in vivo gene therapy. Firstly, a mouse phenylketonuria(PKU) model carrying a pathogenic R408W mutation in phenylalanine hydroxylase(Pah) was generated. Through co-delivery of the general AAV receptor(AAVR), we found that AAVR could dramatically increase AAV transduction efficiency in vitro and in vivo. Furthermore, co-delivery of SaCas9/sgRNA/donor templates with AAVR via AAV8 vectors increased indel rate over 2-fold and HR rate over 15-fold for the correction of the single mutation in Pah;mice. Moreover, AAVR co-injection successfully increased the site-specific insertion rate of a 1.4 kb Pah cDNA by 11-fold, bringing the HR rate up to 7.3% without detectable global off-target effects. Insertion of Pah cDNA significantly decreased the Phe level and ameliorated PKU symptoms. This study demonstrates a novel strategy to dramatically increase AAV transduction which substantially enhanced in vivo genome editing efficiency in adult animal models, showing clinical potential for both conventional and genome editing-based gene therapy. 展开更多
关键词 CRISPR/Cas9 gene therapy adeno-associated virus(AAV) AAVR PAH PKU
原文传递
Tensile and Isothermal Fatigue Behaviors of Mg-12Gd-3Y-0.5Zr Alloy at High Temperature 被引量:2
5
作者 Xiaoming Yang Huajie Yang +4 位作者 Fan Yang shuming yin Wei Wang Shouxin Li Qudong Wang 《Journal of Materials Science & Technology》 SCIE EI CAS CSCD 2009年第6期731-737,共7页
Tensile and isothermal fatigue tests were carried out on an as-rolled Mg-12Gd-3Y-0.5Zr alloy and its heat-treated counterpart at different temperatures. The experimental results show that the ultimate tensile strength... Tensile and isothermal fatigue tests were carried out on an as-rolled Mg-12Gd-3Y-0.5Zr alloy and its heat-treated counterpart at different temperatures. The experimental results show that the ultimate tensile strengths of two alloys decrease very slowly with increasing temperature up to 200℃. The ultimate tensile strength of heat-treated Mg-12Gd-3Y-0.5Zr is slight lower than that of as-rolled counterpart; however, the fatigue strength of heat-treated alloy is higher. The mechanism of fatigue failure was investigated by scanning electron microscopy (SEM) and transmission electron microscopy (TEM). It shows that cyclic slip combined with environmental effect may be the main crack initiation mechanism. 展开更多
关键词 Mg-12Gd-3Y-0.5Zr Isothermal fatigue Fatigue strength Tensile strength
原文传递
Long-term correction of hemophilia B through CRISPR/Cas9 induced homology-independent targeted integration 被引量:1
6
作者 Xi Chen Xuran Niu +14 位作者 Yang Liu Rui Zheng Lei Yang Jian Lu shuming yin Yu Wei Jiahao Pan Ahmed Sayed Xueyun Ma Meizhen Liu Fengxiang Jing Mingyao Liu Jiazhi Hu Liren Wang Dali Li 《Journal of Genetics and Genomics》 SCIE CAS CSCD 2022年第12期1114-1126,共13页
CRISPR/Cas9-mediated site-specific insertion of exogenous genes holds potential for clinical applications.However,it is still infeasible because homologous recombination(HR)is inefficient,especially for nondividing ce... CRISPR/Cas9-mediated site-specific insertion of exogenous genes holds potential for clinical applications.However,it is still infeasible because homologous recombination(HR)is inefficient,especially for nondividing cells.To overcome the challenge,we report that a homology-independent targeted integration(HITI)strategy is used for permanent integration of high-specificity-activity Factor IX variant(F9 Padua,R338L)at the albumin(Alb)locus in a novel hemophilia B(HB)rat model.The knock-in efficiency reaches 3.66%,as determined by droplet digital PCR(dd PCR).The clotting time is reduced to a normal level four weeks after treatment,and the circulating factor IX(FIX)level is gradually increased up to 52%of the normal level over nine months even after partial hepatectomy,demonstrating the amelioration of hemophilia.Through primer-extension-mediated sequencing(PEM-seq),no significant off-target effect is detected.This study not only provides a novel model for HB but also identifies a promising therapeutic approach for rare inherited diseases. 展开更多
关键词 Hemophilia B ALB FIX CRISPR/Cas9-mediated HITI Gene therapy
原文传递
Increasing targeting scope of adenosine base editors in mouse and rat embryos through fusion of TadA deaminase with Cas9 variants 被引量:16
7
作者 Lei Yang Xiaohui Zhang +16 位作者 Liren Wang shuming yin Biyun Zhu Ling Xie Qiuhui Duan Huiqiong Hu Rui Zheng Yu Wei Liangyue Peng Honghui Han Jiqin Zhang Wenjuan Qiu Hongquan Geng Stefan Siwko Xueli Zhang Mingyao Liu Dali Li 《Protein & Cell》 SCIE CAS CSCD 2018年第9期814-819,共6页
Dear Editor, The clustered regularly interspaced short palindromic repeat (CRISPR) system has been widely adapted to genome editing to either introduce or correct genetic mutations (Wang et al., 2016). However, du... Dear Editor, The clustered regularly interspaced short palindromic repeat (CRISPR) system has been widely adapted to genome editing to either introduce or correct genetic mutations (Wang et al., 2016). However, due to competition with the dominant non-homologous end-joining (NHEJ) pathway, precise genome modifications through Cas9-stimulated homologous recombination (HR) is inefficient. Through fusion of cytidine deaminases, APOBEC1 (apolipoprotein B editing complex 1) or AID (activation-induced deaminase), with Cas9 variants, several groups have developed the cytidine base editor (BE) systems (Komor et al., 2016; Li et al., 2018; Nishida et al., 2016). The BE system achieves programmable conversion of C-G base pairs to T.A without double-stranded DNA cleavage (Zhou et al., 2017). More recently, adenine base editors (ABEs), which efficiently convert A-T base pairs to G-C in genomic DNA, have been developed via fusion of an engineered tRNA adenosine deaminase (ecTadA from Escherichia coh) with nCas9 (Gaudelli et al., 2017). The ABE system has quickly been adapted to generate disease models and correction of genetic disease in mice (Ryu et al., 2017; Liu et al, 2018). However, whether the editing efficiency and the targeting scope of ABE could be improved is largely unexplored. In this study, we describe the efficient generation of base-edi- ted mice and rats modeling human diseases through ABEs with highest efficiency up to 100%. We also demonstrate an increase of ABE activity through injection of chemically modified tracrRNA and crRNA in mouse zygotes, and the expansion of editing scope by fusion of an ecTadA mutant to SaCas9n-KKH and Casgn-VQR variants in both cells and embryos. Our study suggests that the ABE system is a powerful and convenient tool to introduce precise base conversions in rodents. 展开更多
原文传递
Correction to: Increasing targeting scope of adenosine base editors in mouse and rat embryos through fusion of TadA deaminase with Cas9 variants
8
作者 Lei Yang Xiaohui Zhang +16 位作者 Liren Wang shuming yin Biyun Zhu Ling Xie Qiuhui Duan Huiqiong Hu Rui Zheng Yu Wei Liangyue Peng Honghui Han Jiqin Zhang Wenjuan Qiu Hongquan Geng Stefan Siwko Xueli Zhang Mingyao Liu Dali Li 《Protein & Cell》 SCIE CAS CSCD 2019年第9期700-700,共1页
This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/ licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction ... This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/ licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. 展开更多
关键词 COMMONS licenses unrestricted
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部